摘要
目的观察唾液酸黏附素(Siglec-1)在冠心病(CHD)患者外周血淋巴细胞、单核细胞和中性粒细胞上的表达水平,并探讨其在冠状动脉粥样硬化发病过程中的作用。方法流式细胞术检测57例CHD患者及38名正常对照者外周血淋巴细胞、单核细胞和中性粒细胞Siglec-1的百分率;生化常规测定所有入选者血脂水平。结果流式细胞仪检测发现,Siglec-1在正常对照组及CHD组淋巴细胞和中性粒细胞上均无表达;CHD组单核细胞Siglec-1阳性率为(12.7±2.4)%,显著高于正常对照组[(1.0±0.3)%,P<0.01],而CHD血脂正常组和血脂异常组的Siglec-1阳性率差异无统计学意义。结论作为单核巨噬细胞激活的标志,Siglec-1在外周血淋巴细胞和中性粒细胞上不表达,在正常人单核细胞上表达很低。CHD患者单核细胞Siglec-1表达明显升高,提示CHD患者外周血单核细胞已经激活,发生巨噬细胞化,Siglec-1在单核细胞黏附血管内皮及CHD的发病过程中可能起重要作用。
Objective To investigate the expression of sialic acid-binding immunoglobulin-like lectin-1 (Siglec-1) on peripheral blood lymphocytes, monocytes and neutrophils in patients with coronary heart disease (CHD) and explore the role of Siglec-1 in coronary atherogenesis. Methods The percentage of Siglec-1 in lymphocytes, monocytes and neutrophils was determined by flow cytometry in 57 CHD patients and 38 healthy controls. The levels of serum lipids were determined by clinical chemistry analyzer. Results Siglec-1 protein was not found on lymphocytes and neutrophils in both CHD patients and healthy controls. The positive rate of Siglec-1 on monocytes in CHD patients was significantly higher than that in healthy controls[ ( 12.7 ± 2.4) % vs ( 1.0 ± 0.3 ) % , P 〈 0.01 ]. However, no significant difference was found between normal and abnormal levels of serum lipids in CHD patients. Conclusions As a major biomarker of the activation of monocytes/macrophages, Siglec-1 is not expressed on peripheral blood lymphocytes and neutro- phils and is lightly expressed on monocytes in healthy controls. The increasing expression of Siglec-1 in CHD patients demonstrates the activation of monocytes in peripheral blood. Siglec-1 may mediate monocytes adhere to vascular endothelial ceils and play an important role in the pathogenesis of CHD.
出处
《检验医学》
CAS
北大核心
2009年第9期667-670,共4页
Laboratory Medicine
基金
国家高科技研究发展计划(863计划
2006AA02Z496)
上海市科学技术委员会优秀学科带头人基金资助项目(07XD14013)
关键词
唾液酸黏附素
冠状动脉粥样硬化
流式细胞术
Sialic acid-binding immunoglobulin-like lectin-1
Coronary heart disease
Flow cytometry